India: Delhi High Court Restrains Natco From Dealing With Anti-Cancer Drug Olaparib - Anand & Anand
Published
Delivering an injunction in favour of AstraZeneca, the Delhi High Court has restrained Natco from manufacturing and selling, or in any manner...
Full Article